Status:
RECRUITING
Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma
Lead Sponsor:
Charles University, Czech Republic
Collaborating Sponsors:
Ministry of Health, Czech Republic
University Hospital Hradec Kralove
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Bronchial Asthma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Comprehensive assessment and interventions to promote adherence to inhaled therapy in patients with bronchial asthma and chronic obstructive pulmonary disease involving health care professionals carin...
Detailed Description
Nonadherence to inhaled therapy is a significant problem in patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD), which has a negative impact on the patients´ health as...
Eligibility Criteria
Inclusion
- PATIENTS
- signed informed consent,
- age ≥ 18 years,
- previously diagnosed BA/COPD meeting GOLD 2024 and GINA 2024 diagnostic criteria,
- ability to cooperate,
- at least 8 weeks without exacerbation,
- use of a particular inhaler for at least 3 months.
Exclusion
- pre-terminal/terminal stage of any disease,
- uncooperative patient,
- significant limitation of mobility or cognitive functions.
- HEALTHCARE PROFESSIONALS
- Inclusion Criteria:
- signed informed consent,
- completed education in medicine, pharmacy, or nursing,
- more than one year of working experience,
- care for patients taking inhaled therapy for BA/COPD.
Key Trial Info
Start Date :
June 3 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT07183657
Start Date
June 3 2025
End Date
December 31 2028
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Hradec Králové
Hradec Králové, Czechia, 500 05